INTEGRATING EXPOSURE AND COGNITIVE THERAPIES IS KEY
Offer any patient who meets criteria for PTSD a referral for exposure therapy and trauma-focused cognitive behavioral therapy (TF-CBT), the first-line treatments for PTSD.1,4,8,24,25
Exposure therapies for PTSD are supported by strong evidence and help patients to become desensitized to distressful memories through gradual, repeated exposures in a relaxed or safe space.8,26
Cognitive methods, such as cognitive processing therapy, cognitive behavioral therapy, and cognitive reprocessing have moderate strength of evidence, and may be combined with exposure therapy.26 Cognitive therapies help patients change thoughts, beliefs, and behaviors that contribute to PTSD symptoms.8,26
Exposure and TF-CBT have the most empirical evidence for child, adolescent, and adult PTSD, and are effective for the range of PTSD symptoms,4,8,25 including avoidance—a fundamental component of PTSD that drives other PTSD symptoms27—comorbid depression, and other emotions associated with trauma (eg, shame, guilt, and anger).8,25 Family involvement is recommended for children and adolescents.4
For patients with comorbid substance abuse, offer integrated PTSD/substance abuse treatment, which is more effective than isolated treatment of each.4 Relaxation training can be helpful as an adjunct to TF-CBT, but is not sufficient as a stand-alone treatment.13 Other psychotherapies, such as supportive, psychodynamic, systemic, and hypnotherapy, have not proved effective.14
Eye Movement Desensitization and Reprocessing (EMDR), a much publicized but controversial treatment, integrates components of exposure and cognitive therapies with therapist-directed eye movements.28-30 Patients imagine their trauma while the therapist directs their eye movements, which is thought to provide exposure to trauma images and memories, thereby reducing symptoms. EMDR has been found to reduce PTSD symptoms with a low to moderate strength-of-evidence rating.26 However, it has not proved more effective than other exposure and cognitive therapies, and its unique component (eg, eye movements) has not added any effect to outcomes.28-31
Other newer therapies, such as Acceptance and Commitment Therapy7,24,27 and online and computer-assisted treatments, are being evaluated.14
Medications take on an adjunct role to therapy
Drug treatment of PTSD has not been effective in children or adolescents.4,8 In adults, medications have helped relieve some symptoms of PTSD. However, given their low effect sizes, medications are not recommended as first-line treatments over exposure and TF-CBT. Their usefulness lies chiefly in an adjunct role to exposure and cognitive therapies or for patients who refuse psychotherapy.4,8,25
Selective serotonin reuptake inhibitors such as fluoxetine, paroxetine, and sertraline, have been effective for such PTSD symptoms as intrusive thoughts, negative or irritable mood, anxiety, restlessness, attention difficulties, and hyperarousal.1,8
While benzodiazepines have been used to control anxiety, hyperarousal, and insomnia, they have not been effective for most other PTSD symptoms, including avoidance, re-experiencing, and cognitive symptoms. Furthermore, they are not recommended given their augmentative effect on other related symptoms and associated conditions (eg, dissociation, disinhibition, substance abuse) and possible interference with desensitization that occurs in exposure therapy.1,5
If a patient has significant insomnia and PTSD-related nightmares, consider starting prazosin at 1 mg/d and titrating up to an effective dose, which typically ranges from 5 to 20 mg per day.1,5 Additionally, trazodone or antihistamines may be used to enhance sleep.1